Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1885864

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1885864

Protein Hydrolysates for Wound Healing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Protein Hydrolysates for Wound Healing Market was valued at USD 892.5 million in 2024 and is estimated to grow at a CAGR of 12.1% to reach USD 2.8 billion by 2034.

Protein Hydrolysates for Wound Healing Market - IMG1

Market expansion is driven by increasing awareness of advanced wound care technologies and the rising prevalence of chronic wounds worldwide. Protein hydrolysates derived from collagen, keratin, and gelatin play a critical role in accelerating tissue repair due to their rich amino acid content and bioactive peptides. These compounds help stimulate tissue regeneration, support collagen formation, and minimize inflammation, ultimately promoting faster healing and reduced scarring. Their strong biocompatibility makes them well-suited for medical applications across wound dressings, topical solutions, and regenerative medicine. Growing incidences of diabetic ulcers, pressure injuries, and postoperative wounds continue to increase demand, while the aging global population further strengthens the need for effective wound management products. As healthcare providers pursue solutions that enhance cellular activity and improve healing environments, the market is expected to see significant opportunities for innovation and product expansion.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$892.5 Million
Forecast Value$2.8 Billion
CAGR12.1%

The collagen hydrolysates segment held a 45% share in 2024, supported by proven clinical benefits, regulatory approvals, and broad applicability. These products originate from multiple sources, including bovine, porcine, equine, avian, and marine materials, with animal-based variants currently holding the strongest commercial position even as interest grows in alternative marine and recombinant formulations.

The powder-based protein hydrolysates segment held 55.1% share in 2024. Their long shelf life, high concentration, storage convenience, and versatile application make them appealing for medical settings. Produced through methods like freeze-drying, spray-drying, and vacuum-drying following enzymatic processing, powder formulations provide ease of use for clinicians and patients while remaining cost-effective.

North America Protein Hydrolysates for Wound Healing Market held 40.1% share in 2024 and is projected to grow at a 12.3% CAGR through 2034. Growth in the region is supported by strong healthcare infrastructure, rising cases of chronic wounds, and increasing demand for innovative wound care technologies. Greater acceptance of minimally invasive approaches and expanded research and development activity continue to drive advancements. Ongoing interest in personalized care and next-generation wound management solutions positions North America as a major contributor to global market expansion.

Key companies in the Global Protein Hydrolysates for Wound Healing Market include FrieslandCampina, Ingredia SA, Medtrition, Hymed, Fonterra NZMP, Arla Foods Ingredients, Hilmar Ingredients, Davisco Foods International, Nutriform, DermaRite, and Glanbia plc. Companies competing in the Protein Hydrolysates for Wound Healing Market are employing a range of strategies to strengthen their market position. Many are expanding production capabilities to meet rising global demand while advancing hydrolysis technologies to improve peptide purity and therapeutic effectiveness. Strategic collaborations with wound care manufacturers and healthcare institutions help accelerate product adoption and support evidence-based validation. Firms are also diversifying their portfolios by developing specialized formulations targeted at chronic wounds, surgical recovery, and regenerative therapies. Sustainability initiatives, such as exploring marine and recombinant sources, support long-term competitiveness and regulatory alignment.

Product Code: 15281

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product type
    • 2.2.3 Physical form
    • 2.2.4 Processing method
    • 2.2.5 Application
  • 2.3 TAM Analysis, 2025-2034
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product type
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and environmental aspects
    • 3.12.1 Sustainable practices
    • 3.12.2 Waste reduction strategies
    • 3.12.3 Energy efficiency in production
    • 3.12.4 Eco-friendly initiatives
  • 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021-2034 (USD Million & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Collagen hydrolysates
    • 5.2.1 Bovine collagen hydrolysates
    • 5.2.2 Porcine collagen hydrolysates
    • 5.2.3 Marine collagen hydrolysates
    • 5.2.4 Avian collagen hydrolysates
  • 5.3 Marine protein hydrolysates
    • 5.3.1 Fish-derived bioactive peptides
    • 5.3.2 Shellfish-derived hydrolysates
    • 5.3.3 Algae-based protein hydrolysates
    • 5.3.4 Jellyfish collagen peptides
  • 5.4 Whey protein hydrolysates
  • 5.5 Specialized amino acid formulations
    • 5.5.1 Arginine-enriched hydrolysates
    • 5.5.2 Glutamine-enhanced formulations
    • 5.5.3 Branched-chain amino acid complexes

Chapter 6 Market Estimates and Forecast, By Physical Form, 2021-2034 (USD Million & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Powder
  • 6.3 Liquid

Chapter 7 Market Estimates and Forecast, By Processing Method, 2021-2034 (USD Million & Kilo Tons)

  • 7.1 Key trends
  • 7.2 Enzymatic hydrolysis
  • 7.3 Acid hydrolysis
  • 7.4 Alkaline hydrolysis
  • 7.5 Combined processing methods

Chapter 8 Market Estimates and Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

  • 8.1 Key trend
  • 8.2 Chronic wound management
    • 8.2.1 Diabetic foot ulcers
    • 8.2.2 Pressure injuries/ulcers
    • 8.2.3 Venous leg ulcers
    • 8.2.4 Arterial ulcers
  • 8.3 Acute wound care
    • 8.3.1 Surgical wounds
    • 8.3.2 Traumatic injuries
    • 8.3.3 Burn treatment
    • 8.3.4 Emergency wound care
  • 8.4 Post-surgical recovery
    • 8.4.1 Orthopedic surgery recovery
    • 8.4.2 Cardiovascular surgery support
    • 8.4.3 General surgery applications
    • 8.4.4 Plastic & reconstructive surgery
  • 8.5 Preventive wound care
    • 8.5.1 High-risk patient nutritional support
    • 8.5.2 Pre-surgical conditioning
    • 8.5.3 Immunocompromised patient care
    • 8.5.4 Geriatric wound prevention

Chapter 9 Market Estimates and Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Arla Foods Ingredients
  • 10.2 Davisco Foods International
  • 10.3 DermaRite
  • 10.4 Fonterra NZMP
  • 10.5 FrieslandCampina
  • 10.6 Glanbia plc
  • 10.7 Hilmar Ingredients
  • 10.8 Hymed
  • 10.9 Ingredia SA
  • 10.10 Medtrition
  • 10.11 Nutriform
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!